Table 3.
Unadjusted associations between baseline characteristics and Kidney function recovery at 6 months | |||||
---|---|---|---|---|---|
Entire Cohort (n=281) | Subgroup excluding CKD5 (n=225) |
||||
Predictors of Kidney function recovery at 6 months* |
Hazard Ratio (95% CI) |
p | Hazard Ratio (95% CI) |
p | |
Age, per 5 year | 0.93 (0.85–1.01) | 0.1 | 0.94 (0.87–1.03) | 0.2 | |
Female gender | 1.43 (0.80–2.50) | 0.2 | 1.39 (0.78–2.44) | 0.3 | |
Caucasian race | 2.19 (0.80–9.02) | 0.1 | 2.11 (0.78–8.67) | 0.2 | |
Diabetes mellitus | 0.64 (0.36–1.12) | 0.1 | 0.58 (0.33–1.03) | 0.06 | |
Coronary artery disease | 0.67 (0.37–1.18) | 0.2 | 0.70 (0.39–1.24) | 0.2 | |
Heart failure | 0.36 (0.19–0.67) | <0.001 | 0.39 (0.20–0.71) | 0.002 | |
Prior outpatient nephrology evaluation | 0.21 (0.09–0.41) | <0.001 | 0.31 (0.14–0.61) | 0.004 | |
Charlson comorbidity score | |||||
Charlson score, per 1 point | 0.84 (0.77–0.91) | <0.001 | 0.85 (0.78–0.93) | <0.001 | |
Charlson score ≥8 | 0.37 (0.19–0.68) | <0.001 | 0.41 (0.21–0.75) | 0.004 | |
Hospital | |||||
ICU vs. non-ICU first dialysis location | 1.96 (1.11–3.44) | 0.02 | 1.59 (0.90–2.79) | 0.1 | |
Time between admission and RRT start, per 1 day | 1.02 (0.98–1.06) | 0.3 | 1.01 (0.96–1.05) | 0.8 | |
Time between RRT start and discharge, per 1 day | 0.99 (0.98–1.01) | 0.8 | 0.99 (0.98–1.00) | 0.4 | |
Length of hospital stay, per 1 day | 1.00 (0.99–1.01) | 0.9 | 1.00 (0.98–1.00) | 0.5 | |
Incident HD year | Incident HD year 2006 | 1.0 (REFERENT) | 1.0 (REFERENT) | ||
Incident HD year 2007 | 2.87 (1.15–8.12) | 0.02 | 3.11 (1.25–8.79) | 0.01 | |
Incident HD year 2008 | 3.45 (1.43–9.57) | 0.005 | 3.20 (1.33–8.86) | 0.009 | |
Incident HD year 2009 | 2.64 (1.02–7.58) | 0.04 | 2.91 (1.13–8.37) | 0.03 | |
First Dialysis access | |||||
Catheters vs. Arteriovenous fistula/graft | 4.95 (1.08–87.55) | 0.03 | 2.76 (0.61–48.93) | 0.2 | |
Arteriovenous fistula/graft | 1.0 (REFERENT) | 1.0 (REFERENT) | |||
Cuffed tunneled catheter | 1.33 (0.23–25.07) | 0.8 | 0.85 (0.15–16.11) | 0.9 | |
Non-cuffed, temporary catheter | 8.22 (1.79–145.75) | 0.003 | 4.11 (0.90–72.91) | 0.08 | |
Renal failure type subgroups | |||||
Acute kidney injury | 1.0 (REFERENT) | 1.0 (REFERENT) | |||
Acute on chronic kidney disease | 0.25 (0.14–0.45) | <0.001 | 0.25 (0.14–0.45) | <0.001 | |
Chronic kidney disease stage 5 | 0.00 (0.00–0.04) | <0.001 | Not included | ||
Acuity unknown | 0.09 (0.01–0.31) | <0.001 | 0.09 (0.01–0.31) | <0.001 | |
Sepsis/Postoperative ATN vs. other AKI & non-AKI | 3.33 (1.90–5.93) | <0.001 | 2.57 (1.46–4.58) | 0.001 | |
Acute and chronic pathology subgroups | |||||
Sepsis/Postoperative ATN pathology | 1.0 (REFERENT) | 1.0 (REFERENT) | |||
Non-Sepsis/Postoperative ATN pathology | 0.51 (0.28–0.89) | 0.02 | 0.53 (0.30–0.92) | 0.03 | |
Chronic pathology only | 0.00 (0.00–0.07) | <0.001 | 0.0 (0.00–0.00) | <0.001 | |
GFR Measurements: n= 253 | n= 197 | ||||
eGFR, per 10 ml/min/1.73m2 | 1.30 (1.21–1.40) | <0.001 | 1.24 (1.15–1.34) | <0.001 | |
eGFR ≥30 ml/min/1.73m2 | 7.50 (3.78–16.56) | <0.001 | 4.40 (2.22–9.71) | <0.001 | |
Multivariable-adjusted#
associations between baseline characteristics and Kidney function recovery at 6 months | |||||
Predictors of Kidney function recovery at 6 months with acute and acute on chronic |
Hazard Ratio (95% CI) |
p |
Hazard Ratio (95% CI) |
p | |
Variable (n=253) | (n=197) | ||||
ICU location of first dialysis | 0.83 (0.44–1.56) | 0.6 | - | - | |
First dialysis access was a catheter | 1.74 (0.36–31.34) | 0.6 | - | - | |
Heart Failure | 0.40 (0.19–0.78) | 0.007 | 0.38 (0.19–0.74) | 0.004 | |
Sepsis/Postoperative ATN pathology | 3.34 (1.83–6.24) | <0.001 | 2.78 (1.54–5.13) | <0.001 | |
eGFR, per 10 ml/min/1.73m2 | 1.27 (1.16–1.39) | <0.001 | 1.21 (1.11–1.32) | <0.001 |
Subgroup analysis excluded CKD5 patients (n=56) with baseline eGFR<15 mL/min/1.73m2;
CKD: chronic kidney disease; eGFR: estimated glomerular filtration rate calculated from the CKD-Epi equation; Charlson score: Charlson comorbidity index score; AKI: acute kidney injury; HD: hemodialysis; ICU: intensive care unit; RRT: renal replacement therapy.
Sepsis/Postoperative ATN pathology includes all patients (AKI or Acute on Chronic injury) with sepsis or postoperative clinical or pathological etiologies.
Adjusted for each other variable in the model, excluding patients with unknown baseline eGFR in the subgroup analysis.